Skip to content

Wave Life Sciences WVE Earnings yield

Earnings yield at other companies

Eli Lilly logo
Eli LillyLLY
3.1%+1.6pp
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-4%-4.3pp
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-2.6%-1.1pp
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
-2.6%-0.9pp
ALN
Alnylam PharmaceuticalsALNY
1.1%+0.8pp
Beam Therapeutics logo
Beam TherapeuticsBEAM
-16.9%

Other financials

Income statement

See full
Revenue$38.2M+317%
Operating income-$31.3M+37.2%
Net income-$26.1M+44.4%
EPS (diluted)-$0.13+55.2%

Balance sheet

See full
Cash & equivalents$544.6M+124%
Total debt$15.7M-33.4%
Total equity$511.7M+198%
Total assets$583.5M+102%

Cash flow

See full
Operating cash flow-$59.6M+5.5%
CapEx$438.0K+165%
Free cash flow-$60.0M+5.1%

Valuation

See full
Market cap$1.14B+13.0%
Enterprise value$615.92M-22.3%
P/S15.1×-12.2×

Profitability

See full
Operating margin-75.7%-33.6pp
Net margin-66.5%-29.9pp
FCF margin-27.2%-12.6pp

Returns & leverage

See full
Return on equity-53.7%
Debt / equity-0.1×
Current ratio11.3×+8.3×

Where this comes from

Calculated from Wave Life Sciences’s reported figures.

Based on trailing twelve months.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Wave Life Sciences's earnings yield?
Wave Life Sciences (WVE) reported earnings yield of -13.5% in Q1 2026.
What is the long-term trend for Wave Life Sciences's earnings yield?
Over 4 years (2020 to 2025), Wave Life Sciences's earnings yield has grown at a -33.1% compound annual growth rate (CAGR), from -32.4% to -6.5%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.